166 related articles for article (PubMed ID: 37404200)
1. Effect of bariatric surgery on endometrial cancer regression as part of fertility sparing treatment.
Lin J; Ho WY; Lim QX; Chin HXF
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1857. PubMed ID: 37404200
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer patients understanding and interest in weight loss surgery.
Wiley RL; Urbauer DL; Nugent E; Gallegos J; Ramondetta L
Gynecol Oncol; 2023 Aug; 175():88-92. PubMed ID: 37329873
[TBL] [Abstract][Full Text] [Related]
3. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Leone Roberti Maggiore U; Martinelli F; Dondi G; Bogani G; Chiappa V; Evangelista MT; Liberale V; Ditto A; Ferrero S; Raspagliesi F
J Gynecol Oncol; 2019 Jul; 30(4):e57. PubMed ID: 31074240
[TBL] [Abstract][Full Text] [Related]
5. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L
Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopy and weight loss in treatment of endometrial cancer: case report and literature review.
Gallo A; D'alisa R; Di Spiezio Sardo A; Guerra S; Berardi G; Vitale SG; Palumbo M; Cretella P; Angioni S; Bifulco G; Musella M
Minim Invasive Ther Allied Technol; 2024 Apr; 33(2):109-119. PubMed ID: 38108527
[TBL] [Abstract][Full Text] [Related]
7. [Fertility sparing treatment of endometrial carcinoma].
Luijten MMW; van Weelden WJ; de Kroon CD; Pijnenborg JMA; van Gent MDJM
Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129891
[TBL] [Abstract][Full Text] [Related]
8. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
Gonthier C; Piel B; Touboul C; Walker F; Cortez A; Luton D; Daraï E; Koskas M
Anticancer Res; 2015 Dec; 35(12):6799-804. PubMed ID: 26637899
[TBL] [Abstract][Full Text] [Related]
9. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
Gong Q; Chen X; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
Mitsuhashi A; Sato Y; Kiyokawa T; Koshizaka M; Hanaoka H; Shozu M
Ann Oncol; 2016 Feb; 27(2):262-6. PubMed ID: 26578736
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).
Mitsuhashi A; Kawasaki Y; Hori M; Fujiwara T; Hanaoka H; Shozu M
BMJ Open; 2020 Feb; 10(2):e035416. PubMed ID: 32114477
[TBL] [Abstract][Full Text] [Related]
12. [Analyze of obesity indicators and effect of fertility preservation treatment in patients with endometrial atypical hyperplasia and early endometrial cancer].
Bo LL; Wang YQ; Liu YY; Li XD; Zhou R; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):767-774. PubMed ID: 36299180
[No Abstract] [Full Text] [Related]
13. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
Xi Y; Liu G; Liu D; Jiang J; Gong R
Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of fertility-sparing therapy of patients with complex atypical hyperplasia and endometrial cancer].
Morimoto C; Wang YQ; Zhou R; Wang JL
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):936-942. PubMed ID: 36241236
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of bariatric surgery in people with endometrial cancer and atypical hyperplasia: A qualitative study.
Kim SR; Ene GEV; Simpson A; Gesink D; Ferguson SE
Gynecol Oncol; 2023 Feb; 169():12-16. PubMed ID: 36463795
[TBL] [Abstract][Full Text] [Related]
17. The role of hysteroscopy in fertility preservation in endometrial cancer and atypical endometrial hyperplasia: a semi-systematic literature review.
Bilir E; Kahramanoğlu İ
Arch Gynecol Obstet; 2023 Oct; 308(4):1113-1126. PubMed ID: 36807742
[TBL] [Abstract][Full Text] [Related]
18. IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management.
Vaugon M; Peigné M; Phelippeau J; Gonthier C; Koskas M
Reprod Biomed Online; 2021 Sep; 43(3):495-502. PubMed ID: 34315696
[TBL] [Abstract][Full Text] [Related]
19. The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment.
Song Z; Liu H; Zhou R; Xiao Z; Wang J; Wang H; Lu Q
Arch Gynecol Obstet; 2022 May; 305(5):1215-1223. PubMed ID: 34762188
[TBL] [Abstract][Full Text] [Related]
20. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]